ListarArtículos (Medicina) por materia "Available therapy"
Mostrando ítems 1-1 de 1
-
Artículo
Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study
(Springer Nature, 2020)Graft-versus-host disease is the main cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation. ...